Home
Who we are
Pipeline
News
Contact
ORPHELIA Pharma
is a biopharmaceutical company dedicated to the development and marketing of pediatric drugs in oncology and neurology.
Our mission is is to develop essential medicines to improve
care and support of pediatric orphan diseases.
Latest news and reports
Latest news and report
1 octobre 2018
Granting of the marketing authorization for Kigabeq®
Read more
28 août 2018
ORPHELIA Pharma will be present at CPhI in Madrid
Read more
28 août 2018
CHMP has adopted a positive opinion for Kigabeq®
Read more
25 juin 2018
Pierre Attali joins ORPHELIA Pharma Board Of Directors
Read more
28 mars 2018
ORPHELIA at the 2018 BIO Convention in Boston
Read more
28 mars 2018
ORPHELIA at the 2018 ASCO annual meeting in Chicago
Read more
28 mars 2018
ORPHELIA at the 2018 ANR meeting in San Francisco
Read more
27 février 2018
ORPHELIA announces the filing of the Marketing Authorization for Kigabeq®
Read more
